Tirzepatide, Pregnancy, and Fertility: Critical Information for Women
Important guidance for women of childbearing age regarding tirzepatide use, fertility changes, contraception, and pregnancy planning.
Women of childbearing age have unique considerations when using tirzepatide. Understanding the fertility and pregnancy implications is essential.
Tirzepatide and Fertility
Increased Fertility Risk
Weight loss from tirzepatide can significantly improve fertility:
- Improved ovulation in women with anovulatory cycles
- Better hormonal balance
- Enhanced reproductive function
- Especially relevant for women with PCOS
This means unplanned pregnancy is a real risk even if you previously had difficulty conceiving.
Pregnancy Contraindications
FDA Pregnancy Category
- Tirzepatide is not recommended during pregnancy
- Animal studies showed potential risks to fetal development
- No adequate human studies exist
- The medication should be discontinued if pregnancy is confirmed or planned
Timing of Discontinuation
- Stop tirzepatide at least 2 months before planned conception (due to its long half-life of ~5 days and potential tissue accumulation)
- Use effective contraception throughout treatment
- Notify your provider immediately if you become pregnant while on tirzepatide
Contraception Considerations
Oral Contraceptive Warning
- Tirzepatide delays gastric emptying, which may reduce absorption of oral contraceptives
- Recommended alternatives:
- IUD (copper or hormonal)
- Implant (Nexplanon)
- Injectable (Depo-Provera)
- Patch or ring (though absorption may also be affected)
- If using oral contraceptives: use backup method for 4 weeks after each dose increase
Barrier Methods
- Condoms can serve as backup contraception
- Not recommended as sole method due to higher failure rates
Breastfeeding
- Unknown whether tirzepatide passes into breast milk
- Not recommended during breastfeeding
- Discuss with your provider if breastfeeding is planned
Planning Pregnancy After Tirzepatide
- Discuss timeline with your OB/GYN and prescriber
- Taper off tirzepatide (don't stop abruptly without guidance)
- Wait at least 2 months after last dose before conceiving
- Transition to pregnancy-safe weight management strategies
- Continue prenatal vitamins and folic acid supplementation